Related Experiment Video
Updated: Aug 13, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Novel Use of Intrapericardial Surgicel Injection to Manage Refractory Cardiac Tamponade After Transcatheter Aortic
Kameel Kassab1, Valentino Bianco2, Christian Torres1
1Division of Cardiology, Onvida Health, Yuma, Arizona.
Abstract:
Pericardial effusions and cardiac tamponade are common complications occurring during transcatheter aortic valve replacement and could be life-threatening. Management of tamponade involves emergent pericardiocentesis and addressing the underlying cause. We present a case of refractory cardiac tamponade with continuous hemorrhagic extravasation into the pericardial space in a nonoperative patient, which was managed by injecting Surgicel hemostatic agent into the pericardial space leading to hemostasis and patient stabilization.

